• USFDA completed a pre-approval inspection at Dr. Reddy’s FTO-11 plant in Pydibhimavaram, India.
• Inspection ran Oct. 5-7, 2026; the agency issued a Form 483 with two observations.
• Company plans to respond within the required timeline, raising a potential compliance overhang for pending product approvals from the site.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dr. Reddy's Laboratories Limited published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001575872-26-000683), on October 08, 2026, and is solely responsible for the information contained therein.